{"name":"Formation Biologics","slug":"formation-biologics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiggJBVV95cUxPSXIwNlY4QXpwM1pSTThkajRZenBRWVFPMkVhYW45TkNVX2F3bUlFRFkyQmNTaHpPYy1xdlZTWXk2bHlJNkdNY3ZtR0hzb0NDbzFfMzBlRG5fUnhVSkxYU2lvNFpXM0FIWDNKWk9xWW1wR19qTFJUZExFOXZrdTVHbnVzNC1EemlkWnE2WXl0b0tnS1d5bjRsSWR3cVh4cnZ2Q2dRVVo3SXNLMC11dmJzWjRDeG1GY0FHdGtFNVVTcFNKZ09uNDVZWDl3RlVqdk5lSVJiSkdfbUY3bUUxQlJZLVhQaXZ2dzZLTzFWaXZwbkpCM2U4OThFU1JMSElnWE1ZTnc?oc=5","date":"2026-04-01","type":"trial","source":"Barchart.com","summary":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | DelveInsight - Barchart.com","headline":"Systemic Sclerosis Clinical Trial Pipeline Gains Momentum: 50+ Companies Lead the Charge in Pioneering New Treatments | ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi3AFBVV95cUxQeTFhRzRkVGZoTk81NndPekcwUFFsckVNRm9QbVRJaVJ2WWRkNzY2dGFxV0NfZHV2UE5zanZQMzNpVnNkZ1hRbGM0RFIzSWJ1OU40RUVxbV9FX0lDaW1tUXdNSDhuR1gtV3VqdkUtZ0piT0lVNXhCVmpJc3hqaGhEeWNYY25pQmZOYjN1a0lYTGc4d2ctNHM5UWZ5MVRMR1pXZDRuWTkzRDdCc1lUTHhsRjdjRENkRVJFU3NtTkJFbTl2Mk5CcVp6ZGVrMnZyODl6cEl1cUszZjU0YkNR?oc=5","date":"2026-03-26","type":"deal","source":"scanx.trade","summary":"Aurobindo Pharma Subsidiary CuraTeQ Biologics Partners with STADA for EU Markets - scanx.trade","headline":"Aurobindo Pharma Subsidiary CuraTeQ Biologics Partners with STADA for EU Markets","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1wFBVV95cUxPeDM1c19oTGkxVHZGSEpLLTZIaXltVVRpOTdack5HTjlLbTFkUmgxaGhDNmFqVXJRNGhVTm9KMms3WUs2bnZzYVlLd1JXUjRTWHF0WHpQajd1a095LUJXbk1WQlp3bmJ6eXNKZzZwbWlReDQ4alFrLXRabnJjYUIwU3BjaGFfYUs4OHhPMktRRDhieTF1ZUZkZFdGZENmNEs3VklrQ2hSRDNTTTF0Umo1eURJZmZhVENnaU9qeGkxSi1jckQybjlJOGFxUS1aYXlTN2xSMGY0VQ?oc=5","date":"2026-03-03","type":"pipeline","source":"scanx.trade","summary":"Cipla Forms 60:40 Joint Venture with Kemwell Biopharma for Biologics Development - scanx.trade","headline":"Cipla Forms 60:40 Joint Venture with Kemwell Biopharma for Biologics Development","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-02-25","type":"pipeline","source":"Business Standard","summary":"Aurobindo Pharma shares rise 4% after incorporating Engenra Biologics arm - Business Standard","headline":"Aurobindo Pharma shares rise 4% after incorporating Engenra Biologics arm","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXkFVX3lxTE1CbWV0N05tcG9EcnlOdVY4OW51QklydUg4V29jT1p2TWI4QzFDeFE3cUpYYlRPSF9jeG1yU29jWEc2b0NyTEgzeV8xdkFSdVQ5MmpLeVAwVDMxLWRvdGc?oc=5","date":"2026-01-01","type":"pipeline","source":"ACS Publications","summary":"Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies - ACS Publications","headline":"Ionic Liquids in Pharmaceuticals: A Scoping Review of Formulation Strategies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxOOHlHZmRrYy1VZ2pncGxYcWctU09ZMGRTWC1GbFA2aXNzZ0RKM0ZuUUh0bW9NNmxKSG4wVUZub3F4SXZWc0dyZllsdE9Fek9LYWJnMHVEZXkydzJwcnBtQ3ZWWGY1dG5wTTNBMmV5WDZEUmdJcTVtSVcyYUk2azRFYVluYUZZR3lYbEN4TmRWV1FjcW5UZWo0YWNaWVdKX0JPN0pXWjhQa3hicnQ5R29ubmo1a09IckhQZ0dj?oc=5","date":"2025-10-22","type":"pipeline","source":"PharmTech.com","summary":"Ashland Previews Fall Conference Exhibits, Including Expanded High-Purity Sugar Portfolio - PharmTech.com","headline":"Ashland Previews Fall Conference Exhibits, Including Expanded High-Purity Sugar Portfolio","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOdERkODFuU0pDRVAzeDB0RTdwTEJTQnpGaHVWMDVGV0tVXzVYTmdFZ2RVTXFOa2pWUi1KWFhwWC05US1vQWpUVGFiSUo3V29fMnN1VElTOEp1ZXJxNmFfRlpHcUZwMnhscVJpMFBodW4tZF9SQ1BIc3FGd0gxcUF6bWlEQkF1MDlneXJucU5vVno0d2FYZExrSDVZYzlJUnlBMEE?oc=5","date":"2025-05-23","type":"pipeline","source":"BioWorld News","summary":"Alteogen merges two subsidiaries, forming Alteogen Biologics - BioWorld News","headline":"Alteogen merges two subsidiaries, forming Alteogen Biologics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiowFBVV95cUxNbUJnWUJsX2ZhdTRDaHJySzltel9Dd1R0azNPMFBtaWljdVoxVm9OZ0JOWUZ3N2QxdGRfR1c4bEMwMXBLV0JZNl9wUUlxa29lY0FLVnRISFByU3oxTGF5U1ZrMjBFYlNKRXhxWk5BXzE3VTlENHBvT29GTDMxSktFMElvSjBJT0FzLU5ELW1IWEJ2Z291QS1fMloweXU3RjBwOU8w?oc=5","date":"2025-04-03","type":"pipeline","source":"Contract Pharma","summary":"AGC Biologics Forms Cell and Gene Technologies Division - Contract Pharma","headline":"AGC Biologics Forms Cell and Gene Technologies Division","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxNaWpTeG56S3plUlg3UnBWTWJFYmxoWERYS3dFOF9Zb2U1TURWVjdrU2dWcy1lU1B3MnRDU2pKVXdLMFBwRE5uaUVieXhCV2k0V0c1aDZuUHM3VEk2bnpYcjBlSFdLTHdvaE4ycjVpR2JrN2NMN2M1cGc0WVNnUURUdnM1OU9YelVOZzIyenYyYTFaTTBxZUxWLU1MaFNFT2JNTW0zUmtuczJabEVQTXY0dWtn?oc=5","date":"2025-01-07","type":"regulatory","source":"BioSpace","summary":"Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty - BioSpace","headline":"Big Pharma Rushes to China for Deal Prospecting Despite Regulatory Uncertainty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMia0FVX3lxTE9ubGprWVYtdjlsZzdRSkY5d2h0ZzQwMkYxd0pDTTlrTVZzVkV6NzVzdXpFNUNrczFtdTNTa2FxcUtrQXl2VzJVc255bEl0UnVTZ0wyaVo2NW9QRlpYOXN0b01CY09LSE5CRXZV?oc=5","date":"2024-12-05","type":"patent","source":"Labiotech.eu","summary":"Five biosimilar companies you should know about - Labiotech.eu","headline":"Five biosimilar companies you should know about","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiswFBVV95cUxQcEhYTm1Oc3JCV1ZPdmdJcVFyR1VySHhZbHNyOFFzYW1iNEREWmN4U1FNUXR3OGk4aUVQdFQtMjFaQjl4RkZVN1lieGVxTHNVQXBHaWRUYzdwVXQ4cmUxVktxT0llRmhrZUxRQ3VJcHFzNmZ2S2Q5c04wd2d0RW1PQW1ORVgtOFQxanlKZUZqalhuVDVST011cWFPMjFxRElNSkYyejVMMG9CZDNsNWEtaS1YMA?oc=5","date":"2024-06-26","type":"deal","source":"fiercebiotech.com","summary":"AI-focused Formation secures Sanofi-backed $372M series D to license more drugs - fiercebiotech.com","headline":"AI-focused Formation secures Sanofi-backed $372M series D to license more drugs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgJBVV95cUxPTEJmWjJVVE9GQ1dWUmlabGRXWkxNX3lLY3BIb0VrdlZTalg2LVdkejBfOGNlaDBPMDdfUEU1TzZlNEhTZlVvOG91QUtlV1YyQU5vZm9KakIxNjBlRmVuRVhtNUY1S0ZWSU5QUHZOMXdBSXNuNUtBaWdSWllvRjhXMnpIRnY4SktNQ1BzamxfakVKYWpPLW1TTm1LTkQya2hBdzhOUzRIaVl1UmQzbXRvUzVlX0kxU0xaS3ozOGh6bC1xbllnMnJseGgwenNOT0VqMFZqWFI2eFpfUk5NLVBtMTRqcmFCaXpNUWcyUE1Nc2huTE50aF9EX2tkMjhaa0oySzRlcXFUVXBoQU00SlpYZzZFZDVzbmdodHVOTlJ1NlhxbGx6YWFIYVQzU2IwaTRjLUxxQUp3OWgwa3RwYjQ4cndR?oc=5","date":"2015-06-01","type":"pipeline","source":"Mayo Clinic News Network","summary":"Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a Company Structured to Accelerate Therapeutic Innovation - Mayo Clinic News Netw","headline":"Baxter Ventures, Mayo Clinic and Velocity Pharmaceutical Development Announce the Formation of Vitesse Biologics, LLC, a","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}